SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-22-002676
Filing Date
2022-01-31
Accepted
2022-01-31 09:36:17
Documents
1
Period of Report
2022-01-27

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4172
  Complete submission text file 0001493152-22-002676.txt   5625
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Issuer) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O ARENA PHARMACEUTICALS, INC. 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address
Cabell Christopher (Reporting) CIK: 0001814928 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36199 | Film No.: 22571646